Managed Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dimethaid Research
Drug-development company proposes name change to Nuvo Research
October 9th, 2005
Pharmaceutical developer Dimethaid Research, Inc., (DMX) announced that it is planning to change its name to Nuvo Research, Inc., reflecting the company's change in direction and focus. "We have restructured our operations and adopted a new strategic direction. A new name will be a clear signal that we have changed as a company," said John London, vice chairman of Dimethaid. Under the direction of a new board of directors and management team, Dimethaid has refocused its efforts on drug development. The company has initiated a market-driven pipeline and is looking to foster new partnerships with leading companies that are prepared to share the...
Source: Managed Care Law Weekly (2005-10-09)
|
